Literature DB >> 33291383

AMIC for Focal Osteochondral Defect of the Talar Shoulder.

Christian Götze1, Christian Nieder1, Hanna Felder1, Filippo Migliorini2.   

Abstract

BACKGROUND: The management of a focal osteochondral lesion of the talus (OLT) is challenging. Evidence concerning the role of the autologous matrix-induced chondrogenesis (AMIC) procedure in patients with focal OLT is promising. The purpose of the present study was to investigate clinical outcomes and radiographic findings of the AMIC technique for focal unipolar OLT.
MATERIAL AND METHODS: The present study was performed according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Twenty-four patients who underwent AMIC for focal OLT were prospectively recruited at our institution. All the surgeries were performed by two experienced surgeons through malleolar osteotomy and autologous cancellous bone grafting. The outcomes of interest were the American orthopedic foot and ankle score (AOFAS), the foot-function index (FFI), and the magnetic resonance observation of cartilage repair tissue (MOCART). Surgical duration, hospitalization length, and complications were also collected.
RESULTS: 24 patients were included in the present study. The mean follow-up was 25.17 ± 13.1 months. The mean age of the patients at surgery was 46.75 ± 15.2 years, the mean BMI 26.92 ± 5.7 kg/m2, and 50% (12 of 24) of patients were female. The right ankle was involved in 62.5% (15 of 24) of patients. The mean defect size was 6.95 ± 2.9 mm2. The mean surgical duration was 112 ± 20 min while the mean hospitalization 5.58 ± 1.7 days. At last follow-up, the AOFAS increased by 27.8 points (p < 0.0001), while the FFI reduced by 25.3 points (p < 0.0001) and the MOCART score increased by 28.33 points (p < 0.0001). No complications were observed.
CONCLUSION: The AMIC procedure for focal osteochondral defects of the talar shoulder is feasible and reliable at midterm follow-up.

Entities:  

Keywords:  AMIC; osteochondral defects; osteochondrosis dissecans; talus

Year:  2020        PMID: 33291383      PMCID: PMC7762075          DOI: 10.3390/life10120328

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  49 in total

1.  Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years.

Authors:  Stefan Marlovits; Philipp Singer; Philip Zeller; Irena Mandl; Jörg Haller; Siegfried Trattnig
Journal:  Eur J Radiol       Date:  2005-10-03       Impact factor: 3.528

2.  Comparison of MRI and arthroscopy in modified MOCART scoring system after autologous chondrocyte implantation for osteochondral lesion of the talus.

Authors:  Kyung Tai Lee; Yun Sun Choi; Young Koo Lee; Seung Do Cha; Hyung Mo Koo
Journal:  Orthopedics       Date:  2011-08-08       Impact factor: 1.390

Review 3.  Treatment of articular cartilage lesions of the knee by microfracture or autologous chondrocyte implantation: a systematic review.

Authors:  Sam Oussedik; Konstantinos Tsitskaris; David Parker
Journal:  Arthroscopy       Date:  2015-02-03       Impact factor: 4.772

4.  Characterization of the collagen component of cartilage repair tissue of the talus with quantitative MRI: comparison of T2 relaxation time measurements with a diffusion-weighted double-echo steady-state sequence (dwDESS).

Authors:  M Kretzschmar; O Bieri; M Miska; M Wiewiorski; N Hainc; V Valderrabano; U Studler
Journal:  Eur Radiol       Date:  2014-11-19       Impact factor: 5.315

5.  Autologous Chondrocyte Implantation and Mesenchymal Stem Cells for the Treatments of Chondral Defects of the Knee- A Systematic Review.

Authors:  Filippo Migliorini; Alessandra Berton; Giuseppe Salvatore; Vincenzo Candela; Wasim Khan; Umile G Longo; Vincenzo Denaro
Journal:  Curr Stem Cell Res Ther       Date:  2020       Impact factor: 3.828

6.  [Malleolar osteotomy--osteotomy as approach].

Authors:  A Barg; G Pagenstert; A Leumann; V Valderrabano
Journal:  Orthopade       Date:  2013-05       Impact factor: 1.087

7.  Functional Medium-Term Results After Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A 5-Year Prospective Cohort Study.

Authors:  Oliver Gottschalk; Sebastian Altenberger; Sebastian Baumbach; Stefanie Kriegelstein; Florian Dreyer; Alexander Mehlhorn; Hubert Hörterer; Andreas Töpfer; Anke Röser; Markus Walther
Journal:  J Foot Ankle Surg       Date:  2017-06-21       Impact factor: 1.286

8.  Open reconstruction with autologous spongiosa grafts and matrix-induced chondrogenesis for osteochondral lesions of the talus can be performed without medial malleolar osteotomy.

Authors:  Mellany Galla; Ian Duensing; Timothy L Kahn; Alexej Barg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-07-17       Impact factor: 4.342

9.  Clinical outcome and T2 assessment following autologous matrix-induced chondrogenesis in osteochondral lesions of the talus.

Authors:  Eva Johanna Kubosch; Benjamin Erdle; Kaywan Izadpanah; David Kubosch; Markus Uhl; Norbert P Südkamp; Philipp Niemeyer
Journal:  Int Orthop       Date:  2015-09-08       Impact factor: 3.075

Review 10.  Treatment of osteochondral lesions of the talus: a systematic review.

Authors:  Maartje Zengerink; Peter A A Struijs; Johannes L Tol; Cornelis Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-27       Impact factor: 4.342

View more
  8 in total

1.  Matrix-induced autologous chondrocyte implantation (mACI) versus autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the knee: a systematic review.

Authors:  Filippo Migliorini; Jörg Eschweiler; Christian Götze; Arne Driessen; Markus Tingart; Nicola Maffulli
Journal:  Br Med Bull       Date:  2022-03-21       Impact factor: 5.841

2.  Cell therapies for chondral defects of the talus: a systematic review.

Authors:  Filippo Migliorini; Jörg Eschweiler; Christian Goetze; Torsten Pastor; Riccardo Giorgino; Frank Hildebrand; Nicola Maffulli
Journal:  J Orthop Surg Res       Date:  2022-06-11       Impact factor: 2.677

3.  Autologous matrix-induced chondrogenesis is effective for focal chondral defects of the knee.

Authors:  Filippo Migliorini; Nicola Maffulli; Alice Baroncini; Andreas Bell; Frank Hildebrand; Hanno Schenker
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

4.  Autologous Matrix-Induced Chondrogenesis (AMIC) and Microfractures for Focal Chondral Defects of the Knee: A Medium-Term Comparative Study.

Authors:  Filippo Migliorini; Jörg Eschweiler; Nicola Maffulli; Hanno Schenker; Alice Baroncini; Markus Tingart; Björn Rath
Journal:  Life (Basel)       Date:  2021-02-25

5.  Mesenchymal stem cells augmentation for surgical procedures in patients with symptomatic chondral defects of the knee: a systematic review.

Authors:  Migliorini Filippo; Mangiavini Laura; Giorgino Riccardo; Vismara Valeria; Jörg Eschweiler; Nicola Maffulli
Journal:  J Orthop Surg Res       Date:  2022-09-14       Impact factor: 2.677

6.  Allograft Versus Autograft Osteochondral Transplant for Chondral Defects of the Talus: Systematic Review and Meta-analysis.

Authors:  Filippo Migliorini; Nicola Maffulli; Alice Baroncini; Jörg Eschweiler; Matthias Knobe; Markus Tingart; Hanno Schenker
Journal:  Am J Sports Med       Date:  2021-09-23       Impact factor: 7.010

7.  Autologous matrix induced chondrogenesis (AMIC) as revision procedure for failed AMIC in recurrent symptomatic osteochondral defects of the talus.

Authors:  Filippo Migliorini; Hanno Schenker; Nicola Maffulli; Jörg Eschweiler; Philipp Lichte; Frank Hildebrand; Christian David Weber
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

8.  Autologous Matrix Induced Chondrogenesis (AMIC) Compared to Microfractures for Chondral Defects of the Talar Shoulder: A Five-Year Follow-Up Prospective Cohort Study.

Authors:  Filippo Migliorini; Jörg Eschweiler; Nicola Maffulli; Hanno Schenker; Arne Driessen; Björn Rath; Markus Tingart
Journal:  Life (Basel)       Date:  2021-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.